If you are considering stopping GLP-1 therapy, discuss a structured monitoring plan with your GP or specialist, including regular checks of HbA1c, weight, blood pressure and lipids
They work synergistically through different mechanisms, with combined administration producing approximately five times greater GH release than either compound alone
As the trials progress, CagriSema could become a key player in the field of obesity treatment, offering a potent option for individuals struggling to lose weight
Sultan evaluates therapies thoughtfully and incorporates those that align with her philosophy of personalized, patient centered care
Additionally, PD-1/PD-L1 immune checkpoint inhibitors are currently under clinical investigation for AD
Despite FDA registration , they are not FDA approved , offer no medical care, lack clinical evidence for effectiveness, misuse GLP-1 terminology in marketing, and have mixed reviews with many users reporting no results